Privacy notice

We would like to set cookies on your device as described in our cookie policy. If you're OK with this then please accept and continue. Alternatively you can control which cookies are set via our cookie settings page.

This statement provides guidance on contraceptive choices for transgender and non-binary people and their partners, who are engaging in vaginal sex where there is a risk of pregnancy. The statement also offers general sexual health advice for these groups.

A transgender individual is someone whose gender identity is not congruent with the sex they were assigned at birth. A transgender woman is someone who was assigned the sex of male, but identifies as a woman. A transgender man is someone who was assigned the sex of female, but identifies as a man. The term transgender is often shortened to ‘trans’. The term non-binary describes any gender identity which does not fit the male and female binary.

It should be stressed that trans people may or may not elect to seek medical help and that, if sought, this medical help is highly individualised. People’s goals from hormone use and surgery vary; therefore, so will appropriateness and acceptability of different methods of contraception. Sensitive communication, with a clear attempt to avoid any stigmatising language, is a key issue.

The clinical guidance in this statement is largely informed by consensus of experts in this field to support healthcare professionals in providing a high standard of contraception and sexual health care for these groups.

Related Documents

Filter news

About FSRH

FSRH is a faculty of the Royal College of the Obstetricians and Gynaecologists.
It was established on the 26th March 1993 as the Faculty of Family Planning and Reproductive Health Care.
Our specialist committees of SRH doctors and nurses work together to produce high quality training programmes,
specialist conferences and events, clinical guidance and other SRH learning resources